Long COVID and the Autonomic Nervous System: The Journey from Dysautonomia to Therapeutic Neuro-Modulation Through the Retrospective Analysis of 152 Patients

Overview

Journal NeuroSci

Specialty Neurology

Date 2024 Nov 1

PMID 39483361

Authors

Joseph Colombo

Michael I Weintraub

Ramona Munoz

Ashish Verma

Ghufran Ahmad

Karolina Kaczmarski

Luis Santos

Nicholas L DePace

Affiliations

Soon will be listed here.

Abstract

Introduction: The severity and prevalence of Post-Acute COVID-19 Sequela (PACS) or long-COVID syndrome (long COVID) should not be a surprise. Long-COVID symptoms may be explained by oxidative stress and parasympathetic and sympathetic (P&S) dysfunction. This is a retrospective, hypothesis generating, outcomes study.

Methods: From two suburban practices in northeastern United States, 152 long COVID patients were exposed to the following practices: (1) first, they were P&S tested (P&S Monitor 4.0; Physio PS, Inc., Atlanta, GA, USA) prior to being infected with COVID-19 due to other causes of autonomic dysfunction; (2) received a pre-COVID-19 follow-up P&S test after autonomic therapy; (3) then, they were infected with COVID-19; (4) P&S tested within three months of surviving the COVID-19 infection with long-COVID symptoms; and, finally, (5) post-COVID-19, follow-up P&S tested, again, after autonomic therapy. All the patients completed autonomic questionnaires with each test. This cohort included 88 females (57.8%), with an average age of 47.0 years (ranging from 14 to 79 years), and an average BMI of 26.9 #/in.

Results: More pre-COVID-19 patients presented with sympathetic withdrawal than parasympathetic excess. Post-COVID-19, these patients presented with this ratio reversed and, on average, 49.9% more autonomic symptoms than they did pre-COVID-19.

Discussion: Both parasympathetic excess and sympathetic withdrawal are separate and treatable autonomic dysfunctions and autonomic treatment significantly reduces the prevalence of autonomic symptoms.

Conclusion: SARS-CoV-2, via its oxidative stress, can lead to P&S dysfunction, which, in turn, affects the control and coordination of all systems throughout the whole body and may explain all of the symptoms of long-COVID syndrome. Autonomic therapy leads to positive outcomes and patient quality of life may be restored.

Citing Articles

The interplay between Sars-Cov-2 infection related cardiovascular diseases and depression. Common mechanisms, shared symptoms.

Gonjilashvili A, Tatishvili S Am Heart J Plus. 2024; 38:100364.

PMID: 38510743 PMC: 10945907. DOI: 10.1016/j.ahjo.2024.100364.

References

Larsen N, Stiles L, Miglis M . Preparing for the long-haul: Autonomic complications of COVID-19. Auton Neurosci. 2021; 235:102841. PMC: 8254396. DOI: 10.1016/j.autneu.2021.102841. View

Roman G, Spencer P, Reis J, Buguet A, Faris M, Katrak S . The neurology of COVID-19 revisited: A proposal from the Environmental Neurology Specialty Group of the World Federation of Neurology to implement international neurological registries. J Neurol Sci. 2020; 414:116884. PMC: 7204734. DOI: 10.1016/j.jns.2020.116884. View

Dixit N, Churchill A, Nsair A, Hsu J . Post-Acute COVID-19 Syndrome and the cardiovascular system: What is known?. Am Heart J Plus. 2021; 5:100025. PMC: 8223036. DOI: 10.1016/j.ahjo.2021.100025. View

Miller A, Arnold A . The renin-angiotensin system in cardiovascular autonomic control: recent developments and clinical implications. Clin Auton Res. 2018; 29(2):231-243. PMC: 6461499. DOI: 10.1007/s10286-018-0572-5. View

Abboud H, Abboud F, Kharbouch H, Arkha Y, El Abbadi N, El Ouahabi A . COVID-19 and SARS-Cov-2 Infection: Pathophysiology and Clinical Effects on the Nervous System. World Neurosurg. 2020; 140:49-53. PMC: 7255736. DOI: 10.1016/j.wneu.2020.05.193. View

Akselrod S . Spectral analysis of fluctuations in cardiovascular parameters: a quantitative tool for the investigation of autonomic control. Trends Pharmacol Sci. 1988; 9(1):6-9. DOI: 10.1016/0165-6147(88)90230-1. View

Fischer L, Barop H, Ludin S, Schaible H . Regulation of acute reflectory hyperinflammation in viral and other diseases by means of stellate ganglion block. A conceptual view with a focus on Covid-19. Auton Neurosci. 2021; 237:102903. PMC: 9761017. DOI: 10.1016/j.autneu.2021.102903. View

Pavlov V, Tracey K . The vagus nerve and the inflammatory reflex--linking immunity and metabolism. Nat Rev Endocrinol. 2012; 8(12):743-54. PMC: 4082307. DOI: 10.1038/nrendo.2012.189. View

Dani M, Dirksen A, Taraborrelli P, Torocastro M, Panagopoulos D, Sutton R . Autonomic dysfunction in 'long COVID': rationale, physiology and management strategies. Clin Med (Lond). 2020; 21(1):e63-e67. PMC: 7850225. DOI: 10.7861/clinmed.2020-0896. View

10.

Porzionato A, Emmi A, Barbon S, Boscolo-Berto R, Stecco C, Stocco E . Sympathetic activation: a potential link between comorbidities and COVID-19. FEBS J. 2020; 287(17):3681-3688. PMC: 7405290. DOI: 10.1111/febs.15481. View

11.

Breit S, Kupferberg A, Rogler G, Hasler G . Vagus Nerve as Modulator of the Brain-Gut Axis in Psychiatric and Inflammatory Disorders. Front Psychiatry. 2018; 9:44. PMC: 5859128. DOI: 10.3389/fpsyt.2018.00044. View

12.

Poloni T, Medici V, Moretti M, Visona S, Cirrincione A, Carlos A . COVID-19-related neuropathology and microglial activation in elderly with and without dementia. Brain Pathol. 2021; 31(5):e12997. PMC: 8412067. DOI: 10.1111/bpa.12997. View

13.

Felten D . Neural influence on immune responses: underlying suppositions and basic principles of neural-immune signaling. Prog Brain Res. 2000; 122:381-9. DOI: 10.1016/s0079-6123(08)62152-4. View

14.

Pergolizzi Jr J, Raffa R, Varrassi G, Magnusson P, LeQuang J, Paladini A . Potential neurological manifestations of COVID-19: a narrative review. Postgrad Med. 2020; 134(4):395-405. PMC: 7799377. DOI: 10.1080/00325481.2020.1837503. View

15.

Alwan N, Johnson L . Defining long COVID: Going back to the start. Med. 2021; 2(5):501-504. PMC: 7992371. DOI: 10.1016/j.medj.2021.03.003. View

16.

Al-Kuraishy H, Al-Gareeb A, Qusti S, Alshammari E, Gyebi G, El-Saber Batiha G . Covid-19-Induced Dysautonomia: A Menace of Sympathetic Storm. ASN Neuro. 2021; 13:17590914211057635. PMC: 8586167. DOI: 10.1177/17590914211057635. View

17.

Bisaccia G, Ricci F, Recce V, Serio A, Iannetti G, Chahal A . Post-Acute Sequelae of COVID-19 and Cardiovascular Autonomic Dysfunction: What Do We Know?. J Cardiovasc Dev Dis. 2021; 8(11). PMC: 8621226. DOI: 10.3390/jcdd8110156. View

18.

Goldstein D . The extended autonomic system, dyshomeostasis, and COVID-19. Clin Auton Res. 2020; 30(4):299-315. PMC: 7374073. DOI: 10.1007/s10286-020-00714-0. View

19.

Wirtz M, Moekotte J, Balvers K, Admiraal M, Pittet J, Colombo J . Autonomic nervous system activity and the risk of nosocomial infection in critically ill patients with brain injury. Intensive Care Med Exp. 2020; 8(1):69. PMC: 7688871. DOI: 10.1186/s40635-020-00359-3. View

20.

Baig A, Khaleeq A, Ali U, Syeda H . Evidence of the COVID-19 Virus Targeting the CNS: Tissue Distribution, Host-Virus Interaction, and Proposed Neurotropic Mechanisms. ACS Chem Neurosci. 2020; 11(7):995-998. DOI: 10.1021/acschemneuro.0c00122. View